








tract is not known. In this study, we tested the hypothesis that sucrose may increase the
expression of cryptdin-5 and cryptdin-7. Methods: To test this hypothesis, we compared
cryptdin-5 and cryptdin-7 expression in the small intestine (proximal, mid and distal 1/3),
colon and liver by real-time PCR. Twenty-four rats were randomized into 1 of 3 treatments
consisting of 24h access to regular rat chow (Control), uncooked red kidney bean-supple-
mented chow (25%) (RKB) or uncooked red kidney bean-supplemented chow (25%) +
sucrose in the drinking water (Sucrose) followed by tissue collection. Data generated by
real-time PCR are represented by 2-ΔΔCt values where Ct represents PCR cycle thresholds
(Methods 2001;25:402-408). Lower 2-ΔΔCt values represent greater gene expression. Data
are mean + SD. Results: 1. In the small intestine, compared with Controls (proximal: 6.72
+ 2.4, mid: 2.5 + 1.2, distal: 2.6 + 1.3), cryptdin-5 expression was increased in the Sucrose
group across the entire length of the organ (proximal: 3.7 + 0.8, mid: 1.2 + 0.6, distal: 0.7
+ 0.5)(p,0.05); 2. In the liver, compared to Controls (12.6 + 2.0), cryptdin-5 expression
was increased in Sucrose (10.8 + 0.9)(p,0.05); 3. Cryptdin-5 expression was also greater
in Sucrose than RKB (p,0.05); 4. Similarly, cryptdin-7 expression in the small intestine
was greater in Sucrose when compared with Controls (p ,0.05) but there was only a trend
for this effect in the liver (p= 0.7); 5. In addition, cryptdin-7 expression was greater in
Sucrose than RKB in the liver (p ,0.05) but not in the small intestine; 6. There was no
effect of sucrose in the colon for either cryptdin-5 or cryptdin-7 expression. Conclusion:
Sucrose increased expression of antimicrobial cryptdin-5 and cryptdin-7 in the small intestine
and liver. Dr. Lin's research is supported by NIH, VA Research and the Department of Defense.
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Role of Endogenous GLP-2 in the Intestinal Adaptation to a Chronic High Fat
Diet
Sara Baldassano, Francesca Rappa, Alessandra Rotondo, Margherita Lo Bello, Francesco
Cappello, Antonella Amato, Flavia Mule'
BACKGROUND AND AIM: Glucagon-like peptide-2 (GLP-2) is a nutrient-dependent peptide
hormone with multiple effects on the intestine, including expansion of the mucosal surface
area through stimulation of crypt cell proliferation and enhancement of nutrient digestion
and absorption. Effects of GLP-2 occur via the GLP-2 receptor (GLP-2R), a G-protein-
coupled receptor, mainly present in the gastrointestinal tract. We sought to determine if
GLP-2 is involved in the regulation of the gut morphological changes following chronic
high fat (HF) diet METHODS: C57BL6/J mice, fed a high fat diet for six weeks, and the
age-matched control animals were injected once a day intraperitoneally (i.p.) with 100 μl
of GLP-2 (3-33), a GLP-2 receptor antagonist (30 or 60 ng) or PBS (vehicle control) for
four weeks. Plasma GLP-2 concentrations, by ELISA, small intestinal GLP-2R expression
levels by real-time RT-PCR and western blot analysis, and intestinal morphometric parameters
were determined. Immunohistochemistry for the proliferative and apoptotic markers, respec-
tively Ki67 and caspase-3 was performed. RESULTS: Compare with age-matched control
animals, HF fed mice exhibited increase of crypt-villus height, cell number per villus and
Ki-67 positive cell number of the crypt region. None difference was seen in the number of
goblet cells per villus and in the thickness of the external muscular layer. The chronic
exposure to HF diet also caused a significant increase in GLP-2 plasma levels and in GLP-
2R intestinal expression. Treatment with GLP-2 (3-33) did not significantly modify the
crypt-villus height in control animals. On the contrary, in HF fed mice administration of
GLP-2 (3-33) significantly reduced the crypt-villus height, the number of cells per villus as
well as the number of Ki-67 positive cells, and it increased the percent of caspase-3 positive
cells in the small intestine. CONCLUSIONS: This study suggests that GLP-2 may play a
role in the murine intestinal adaptation to HF diet, leading to enhancing energy intake.
Prolonged HF diet could induce dysregulation of GLP-2/GLP-2R system. Supported by
MIUR, Italy
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Enteral Deprivation Leads to a Loss of Intestinal Epithelial Barrier Function
Matthew W. Ralls, Daniel H. Teitelbaum, Eiichi A. Miyasaka, Kathy M. Ignatoski
Objective: Total parenteral nutrition (TPN) increases risk of infections versus enteral feeding.
As a major source of these infections is the gastrointestinal tract, we hypothesized that
underfed mucosa has decreased epithelial barrier function (EBF), and tested this in a series
of human resection specimens.. Methods: Small bowel, excluding Crohn's disease, was
obtained from pediatric patients (aged 2 days to 19 years) undergoing intestinal resection.
EBF was assessed in Ussing chambers for trans-epithelial resistance(TER) and passage of
FITC-Dextran(4kD). Immunofluorescence staining was used to evaluate intensity and distri-
bution of tight junctional (TJ) and adherence junctional (AJ) proteins. Abundance of junc-
tional proteins was also measured with Western Immunoblot. Statistical significance for TER
used Student T-test. Results: Interestingly, initial examination of specimen(N=22) failed to
correlate lack of feeding and TER(p=0.09). However, in fed samples, TER increased with
patient age (p,0.01). Therefore results were then stratified by patient's age. Fully fed bowel
had significantly higher TER versus unfed bowel in teenagers(p ,0.05). This trend was also
observed in infants(p=0.053). These changes in TER correlated with permeation of FITC-
Dextran(p=0.03). We next correlated these findings with Western immunoblot. There was
an increase in protein abundance in unfed patients. To localize these protein, we next looked
at immunofluorescence staining. Dramatic declines in staining of ZO-1, occludin, E-cadherin
and Claudin-1 were observed in unfed segments. Conclusion: EBF declined in unfed segments
of human bowel. This finding may explain increased infectious complications seen in patients
not receiving enteral feeds.
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Differences in the Degree of Cerulein Induced Chronic Pancreatitis in C57BL/
6 Mouse Substrains Lead to New Insights in Identification of Potential Risk
Factors in the Development of Chronic Pancreatitis
Barbara Ulmasov, Kiyoko Oshima, Michael G. Rodriguez, Roger D. Cox, Brent A.
Neuschwander-Tetri
A frequently used experimental model of chronic pancreatitis (CP) recapitulating human
disease is repeated injection of cerulein to mice. C57BL/6 is the most commonly used inbred
strain for biomedical research, but widespread demand led to the creation of several substrains
with subtly different phenotypes. In this study we found that two common substrains of
C57BL/6, C57BL/6J and C56BL/6NHsd , exhibit different degrees of CP with C57BL/6J
being more susceptible to repetitive cerulein-induced CP as assessed by pancreatic atrophy,
pancreatic morphological changes and fibrosis. We hypothesized that the deficiency of
nicotinamide nucleotide transhydrogenase (NNT) protein in C57BL/6J was responsible for
the more severe C57BL/6J phenotype but the parameters of CP in NNT expressing transgenic
mice created on C57BL6/J background were undistinguished from the wild type C57BL/6J.
The highly similar genetic backgrounds but different CP phenotypes of these two substrains
presents a unique opportunity to discover genes important in pathogenesis of CP. To exploit
this opportunity, we conducted whole mouse genome Affymetrix microarray analysis of
pancreatic gene expression of C57BL/6J and C57BL/6NHsd before and after the induction
of CP. Differentially regulated gene expression between the two substrains that might be
candidates in CP progression included Mmp7, Pcolce2, Itih4 and Vnt. Additionally, we
identified several genes associated with the development in CP in both substrains including
RIKEN 1810009J06 (trypsinogen5), Ccl8 and Ccl6.
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Increased Peripheral Cd19+CD24HiCd38Hi Regulatory B Cells May Be Involved
in the Pathophysiology of Type 1 Autoimmune Pancreatitis
Kimi Sumimoto, Kazushige Uchida, Toshiyuki Mitsuyama, Yuri Fukui, Takeo Kusuda,
Hideaki Miyoshi, Norimasa Fukata, Masanori Koyabu, Yutaku Sakaguchi, Tsukasa Ikeura,
Masaaki Shimatani, Toshiro Fukui, Mitsunobu Matsushita, Makoto Takaoka, Akiyoshi
Nishio, Kazuichi Okazaki
Background: Autoimmune pancreatitis (AIP) is a newly recognized pancreatic disorder. In
2011, International Consensus Diagnostic Criteria for AIP (ICDC) was published. In this
ICDC, AIP was classified into type 1 and type 2. Patients with type 1 AIP have several
immunologic and histologic abnormalities specific to the disease, including increased levels
of serum immunoglobulin G4 (IgG4) and storiform fibrosis with infiltration of lymphocytes
and IgG4-positive plasmacytes in the involved organs. We previously reported that increased
numbers of inducible costimulatory molecule (ICOS) (+) regulatory T cells (Tregs) might
influence IgG4 production via interleukin-10 (IL-10) in type 1 AIP. In addition to Tregs,
it has been reported that regulatory B cells (Bregs) may also produce IL-10, and be involved
in the development of various autoimmune diseases such as systemic lupus erythematosus
(SLE), immune thrombocytopenia (ITP), and sarcoidosis. However, Bregs has not been
investigated in type 1 AIP. On the other hand, depletion of B cells by rituximab (RTX) is
effective for treatment of IgG4-related systemic disease such as type 1 AIP. However, in
addition to B cell function deleted by RTX, it is unclear whether Bregs are involved in the
development of type 1 AIP or not. To clarify the role of Bregs in the pathophysiology of
type 1 AIP, we analyzed circulating Bregs in type 1 AIP. Methods: We recruited 21 patients
with type 1 AIP on the basis of ICDC for this study. All patients were untreated with
corticosteroids. For comparison, we also recruited 14 patients with chronic pancreatitis
(CP), 18 patients with pancreatic cancer, and 25 healthy subjects as controls. We analyzed
Bregs as CD19+CD24hiCD38hi and IL10+ B cells from peripheral blood by flow cytometry.
Results: In peripheral blood, CD19+CD24hiCD38hi Bregs were significantly increased in type
1 AIP patients (6.44% ± 3.19%) compared with CP (4.58% ± 2.16%, P , 0.05), pancreatic
cancer (3.79% ± 1.97%, P , 0.01), and healthy control (4.84% ± 2.20%, P , 0.05). IL10+
B cells were not significantly different from type 1 AIP and healthy control. In untreated
type 1 AIP patients, the number of CD19+CD24hiCD38hi Bregs and IgG4 were not correlated
(R = 0.334, P 0.14). Conclusions: Our data suggested that CD19+CD24hiCD38hi Bregs may
be involved in the pathophysiology of type 1 AIP via another mechanism rather than IL-
10 production.
